Literature DB >> 24752683

Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria?

Antonio M Quispe1, Edwar Pozo1, Edith Guerrero1, Salomón Durand1, G Christian Baldeviano1, Kimberly A Edgel1, Paul C F Graf1, Andres G Lescano2.   

Abstract

Severe malaria caused by Plasmodium vivax is no longer considered rare. To describe its clinical features, we performed a retrospective case control study in the subregion of Luciano Castillo Colonna, Piura, Peru, an area with nearly exclusive vivax malaria transmission. Severe cases and the subset of critically ill cases were compared with a random set of uncomplicated malaria cases (1:4). Between 2008 and 2009, 6,502 malaria cases were reported, including 106 hospitalized cases, 81 of which fit the World Health Organization definition for severe malaria. Of these 81 individuals, 28 individuals were critically ill (0.4%, 95% confidence interval = 0.2-0.6%) with severe anemia (57%), shock (25%), lung injury (21%), acute renal failure (14%), or cerebral malaria (11%). Two potentially malaria-related deaths occurred. Compared with uncomplicated cases, individuals critically ill were older (38 versus 26 years old, P < 0.001), but similar in other regards. Severe vivax malaria monoinfection with critical illness is more common than previously thought. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2014        PMID: 24752683      PMCID: PMC4080549          DOI: 10.4269/ajtmh.12-0610

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  40 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Severe and fatal vivax malaria challenges 'benign tertian malaria' dogma.

Authors:  J Kevin Baird
Journal:  Ann Trop Paediatr       Date:  2009-12

3.  Malaria in selected non-Amazonian countries of Latin America.

Authors:  Myriam Arevalo-Herrera; Martha Lucia Quiñones; Carlos Guerra; Nora Céspedes; Sandra Giron; Martha Ahumada; Juan Gabriel Piñeros; Norma Padilla; Zilka Terrientes; Angel Rosas; Julio Cesar Padilla; Ananias A Escalante; John C Beier; Socrates Herrera
Journal:  Acta Trop       Date:  2011-07-01       Impact factor: 3.112

4.  Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua.

Authors:  Mazie J Barcus; Hasan Basri; Helena Picarima; C Manyakori; Iqbal Elyazar; Michael J Bangs; Jason D Maguire; J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

5.  Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity.

Authors:  Bruno B Andrade; Antonio Reis-Filho; Sebastião Martins Souza-Neto; Imbroinise Raffaele-Netto; Luis M A Camargo; Aldina Barral; Manoel Barral-Netto
Journal:  PLoS Negl Trop Dis       Date:  2010-04-06

6.  Chloroquine-resistant Plasmodium vivax malaria in Peru.

Authors:  Trenton K Ruebush; Jorge Zegarra; Javier Cairo; Ellen M Andersen; Michael Green; Dylan R Pillai; Wilmer Marquiño; María Huilca; Ernesto Arévalo; Coralith Garcia; Lely Solary; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2003-11       Impact factor: 2.345

7.  Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India.

Authors:  Dhanpat K Kochar; Ashish Das; Sanjay K Kochar; Vishal Saxena; Parmendra Sirohi; Shilpi Garg; Abhishek Kochar; Mahesh P Khatri; Vikas Gupta
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

Review 8.  A research agenda for malaria eradication: vaccines.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

9.  Plasmodium vivax malaria.

Authors:  Dhanpat K Kochar; Vishal Saxena; Narvachan Singh; Sanjay K Kochar; S Vijay Kumar; Ashis Das
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

10.  Serious and fatal illness associated with falciparum and vivax malaria among patients admitted to hospital at West Sumba in eastern Indonesia.

Authors:  Siti Nurleila; Din Syafruddin; Iqbal R F Elyazar; J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

View more
  31 in total

1.  Role of Plasmodium vivax Dihydropteroate Synthase Polymorphisms in Sulfa Drug Resistance.

Authors:  Wichai Pornthanakasem; Pinpunya Riangrungroj; Penchit Chitnumsub; Wanwipa Ittarat; Darin Kongkasuriyachai; Chairat Uthaipibull; Yongyuth Yuthavong; Ubolsree Leartsakulpanich
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Malaria Severity in Mangaluru City in the Southwestern Coastal Region of India.

Authors:  Kiran K Dayanand; Punnath Kishore; Valleesha Chandrashekar; Rajeshwara N Achur; Susanta K Ghosh; Srinivas B Kakkilaya; Suchetha N Kumari; Satyanarayan Tiwari; Archith Boloor; Rajeshwari Devi; D Channe Gowda
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

3.  Severe vivax malaria: a prospective exploration at a tertiary healthcare centre in Southwestern India.

Authors:  Rishikesh Kumar; Kavitha Saravu
Journal:  Pathog Glob Health       Date:  2017-04-03       Impact factor: 2.894

4.  Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin.

Authors:  Tasanee Panichakul; Saranyoo Ponnikorn; Sittiruk Roytrakul; Atchara Paemanee; Suthathip Kittisenachai; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2015-03-31       Impact factor: 2.979

Review 5.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

6.  The prognostic utility of bedside assessment of adults hospitalized with malaria in Myanmar: a retrospective analysis.

Authors:  Myat Kaung; Tint Tint Kyi; Ne Myo Aung; Myat Phone Kyaw; Myo Min; Zaw Win Htet; Nicholas M Anstey; Mar Mar Kyi; Josh Hanson
Journal:  Malar J       Date:  2015-02-07       Impact factor: 2.979

7.  Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India.

Authors:  André M Siqueira; Marcus V G Lacerda; Belisa M L Magalhães; Maria P G Mourão; Gisely C Melo; Márcia A A Alexandre; Maria G C Alecrim; Dhanpat Kochar; Sanjay Kochar; Abhishek Kochar; Kailash Nayak; Hernando del Portillo; Caterina Guinovart; Pedro Alonso; Quique Bassat
Journal:  BMC Med       Date:  2015-03-20       Impact factor: 8.775

8.  Pernicious and threatening Plasmodium vivax as reality.

Authors:  J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2014-04-21       Impact factor: 2.345

9.  Improving the radical cure of Plasmodium vivax malaria.

Authors:  Ric N Price
Journal:  Am J Trop Med Hyg       Date:  2014-04-21       Impact factor: 2.345

Review 10.  Investigating the Pathogenesis of Severe Malaria: A Multidisciplinary and Cross-Geographical Approach.

Authors:  Samuel C Wassmer; Terrie E Taylor; Pradipsinh K Rathod; Saroj K Mishra; Sanjib Mohanty; Myriam Arevalo-Herrera; Manoj T Duraisingh; Joseph D Smith
Journal:  Am J Trop Med Hyg       Date:  2015-08-10       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.